The initial results are promising, but Faubion cautions against putting women on both therapies when they might have a risk factor, like severe obesity, for MHT complications
Daily Administration Schedule: Morning option : 30-60 minutes after waking (on empty stomach) Evening option : 1-2 hours before bed (preferred by most researchers) Consistent timing : Same time daily throughout the active cycle The subcutaneous injection method proves most common, with rotation between injection sites recommended to prevent tissue irritation
Wang JS, Tu ST, Lee IT, Lin SD, Lin SY, Su SL, Lee WJ, Sheu WH
In another subject, general fatigue was described throughout the second week of the injections, with some persistence over the weekend (when no MT-1 was administered)
Int J Surg (London England)